Transaction · 0002024911-26-000006
BIO BIO.BBIO-RAD LABORATORIES, INC.
Engelhardt Eva Anette
ENGELHARDT EVA ANETTE, EVP, PRES, CDG, reported a transaction classified as grant at BIO-RAD LABORATORIES, INC. involving 4313.000000 shares for an estimated $0.00. Reported holdings after the transaction were 4313.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
grantSEC transaction code AEVP, PRES, CDG
- Trade date
- Sep 04, 2026
- Filing date
- Sep 09, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
BIO BIO.B price since this filing
Daily closing prices, with the filing date and available return windowsBIO BIO.B · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y
Transaction facts
Stored Form 4 columns with their raw values
- Type
- grant Code A
- Identifier
- 0002024911-26-000006 Restricted Stock Units
- Transaction date
- Sep 04, 2026 Filed Sep 09, 2026, 10:45 PM · 5d delay
- Shares
- 4,313 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 4,313 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Increase
Filing-only score
-10 points
Compact filing score computed from stored Form 4 facts. Version v1.
Mixed or weak signal
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Reported roles
EVP, President, CDG
Officer YesDirector No10% NoOther No
Footnotes & amended
- F1
Shares of Class A common stock acquired on the vesting of restricted stock units.
- F2
Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
- F3
The restricted stock units vest over four years, with 25% vesting on the first anniversary of the grant date and the remaining units vesting in equal quarterly installments thereafter.
- F4
The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
Related transactions
Same SEC filing0 other transactions
Recent company activity
BIO BIO.B0 recent txs